The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.
ISICEM: CARL attracts international attention
Europe, Australia and the USA: Visitors to the International Symposium on Intensive Care and Emergency Medicine in Brussels (ISICEM) travelled from all over the world to learn and exchange information about the latest topics in intensive care and emergency medicine. “The congress motto “We care intensively” gave us the perfect template to discuss our vision of saving lives after cardiac arrest together with the emergency teams and intensivists on site,” said Thomas Kraft, CEO of Resuscitec. During the symposium days from March 21 to 24 in the Square Brussels Meeting Center, the CARL team presented the product highlights in lively technical discussions and explained the safe application for in-hospital and out-of-hospital resuscitation.
In the workshop “Hands-on CARL – Set up and priming in a resuscitation scenario” the CARL Academy team explained the practical use of CARL technology to the participants in detail. “We are very pleased that we were able to exchange ideas with so many users from different medical fields at the ISICEM Symposium and to give them an understanding of our CARL Technology,” says Patrick Rauh, Commercial Director at Resuscitec GmbH.